Ask AI

On-Demand Webcast

Share

Program Content

Activities

  • Novel ADCs for RR DLBCL
    Novel ADC Therapies for Relapsed/Refractory Large B-Cell Lymphoma: Translating the Latest Advances Into Community Oncology Practice
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 25, 2026

    Expires: August 24, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from ADC Therapeutics and Pfizer Inc.

ADC Therapeutics

Pfizer, Inc.